{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:53:26Z","timestamp":1772582006537,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.mehy.2006.12.012","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T12:56:16Z","timestamp":1170766576000},"page":"422-431","source":"Crossref","is-referenced-by-count":5,"title":["Cornering HIV: Taking advantage of interactions between selective pressures"],"prefix":"10.1016","volume":"69","author":[{"given":"S.","family":"\u00c1vila-R\u00edos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Reyes-Ter\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2006.12.012_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.1996.03530270050031","article-title":"The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention","volume":"275","author":"Hu","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2006.12.012_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrg1246","article-title":"The causes and consequences of HIV evolution","volume":"5","author":"Rambaut","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.mehy.2006.12.012_bib3","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/JVI.69.8.5087-5094.1995","article-title":"Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase","volume":"69","author":"Mansky","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib4","doi-asserted-by":"crossref","first-page":"W13","DOI":"10.1097\/01.aids.0000247564.73009.bc","article-title":"Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004","volume":"20","author":"Hemelaar","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.mehy.2006.12.012_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri1417","article-title":"HIV and SIV CTL escape: implications for vaccine design","volume":"4","author":"Goulder","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mehy.2006.12.012_bib6","first-page":"140","article-title":"Worldwide transmission of drug-resistant HIV","volume":"5","author":"Wensing","year":"2003","journal-title":"AIDS Rev"},{"key":"10.1016\/j.mehy.2006.12.012_bib7","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1069660","article-title":"Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level","volume":"296","author":"Moore","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.mehy.2006.12.012_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.it.2006.09.007","article-title":"Hitting HIV where it hurts: an alternative approach to HIV vaccine design","volume":"27","author":"Altfeld","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.mehy.2006.12.012_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ni0206-121","article-title":"Crosscurrents in HIV-1 evolution","volume":"7","author":"Blankson","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2006.12.012_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm0297-205","article-title":"Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus","volume":"3","author":"Borrow","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2006.12.012_bib11","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.94.5.1890","article-title":"Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection","volume":"94","author":"Price","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2006.12.012_bib12","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.1128\/JVI.79.21.13239-13249.2005","article-title":"Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution","volume":"79","author":"Allen","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ni1281","article-title":"Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes","volume":"7","author":"Frahm","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2006.12.012_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm992","article-title":"HIV evolution: CTL escape mutation and reversion after transmission","volume":"10","author":"Leslie","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2006.12.012_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm998","article-title":"Reversion of CTL escape-variant immunodeficiency viruses in vivo","volume":"10","author":"Friedrich","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2006.12.012_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/0882824041310658","article-title":"Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytes","volume":"17","author":"Peyerl","year":"2004","journal-title":"Viral Immunol"},{"key":"10.1016\/j.mehy.2006.12.012_bib17","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1128\/JVI.79.14.9363-9366.2005","article-title":"Intrapatient escape in the A\u22170201-restricted epitope SLYNTVATL drives evolution of human immunodeficiency virus type 1 at the population level","volume":"79","author":"Edwards","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib18","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1128\/JVI.78.16.8437-8445.2004","article-title":"Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population","volume":"78","author":"Furutsuki","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/35085576","article-title":"Evolution and transmission of stable CTL escape mutations in HIV infection","volume":"412","author":"Goulder","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2006.12.012_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virusres.2005.09.001","article-title":"Patterns of sequence evolution at epitopes for host antibodies and cytotoxic T-lymphocytes in human immunodeficiency virus type 1","volume":"116","author":"Piontkivska","year":"2006","journal-title":"Virus Res"},{"key":"10.1016\/j.mehy.2006.12.012_bib21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1084\/jem.20041455","article-title":"Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA","volume":"201","author":"Leslie","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2006.12.012_bib22","first-page":"125","article-title":"Update of the drug resistance mutations in HIV-1: Fall 2006","volume":"14","author":"Johnson","year":"2006","journal-title":"Top HIV Med"},{"key":"10.1016\/j.mehy.2006.12.012_bib23","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bmj.38665.534595.55","article-title":"Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study","volume":"331","author":"Cane","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2006.12.012_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/315686","article-title":"Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993\u20131998","volume":"182","author":"Weinstock","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mehy.2006.12.012_bib25","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/JVI.78.5.2187-2200.2004","article-title":"Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities","volume":"78","author":"Frahm","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib26","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1128\/JVI.77.12.6743-6752.2003","article-title":"Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene","volume":"77","author":"Karlsson","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib27","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.4049\/jimmunol.172.11.7212","article-title":"Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 Pol epitopes","volume":"172","author":"Mason","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2006.12.012_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/135965350501000409","article-title":"Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1","volume":"10","author":"John","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1016\/j.mehy.2006.12.012_bib29","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.aids.0000171415.07034.0d","article-title":"A therapy-related point mutation changes the HLA restriction of an HIV-1 Pol epitope from A2 to B57 and enhances its recognition","volume":"19","author":"Mason","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.mehy.2006.12.012_bib30","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1128\/JVI.00093-06","article-title":"Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses","volume":"80","author":"Deeks","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib31","doi-asserted-by":"crossref","first-page":"14169","DOI":"10.1128\/JVI.79.22.14169-14178.2005","article-title":"Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment","volume":"79","author":"Emu","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib32","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/JVI.79.6.3653-3663.2005","article-title":"Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapy","volume":"79","author":"Casazza","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ni1298","article-title":"Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope","volume":"7","author":"Iversen","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2006.12.012_bib34","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1002\/eji.200535053","article-title":"Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression","volume":"35","author":"Ali","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mehy.2006.12.012_bib35","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.4049\/jimmunol.171.8.3999","article-title":"Broadly increased sensitivity to cytotoxic T lymphocytes resulting from Nef epitope escape mutations","volume":"171","author":"Ali","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2006.12.012_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-2478(01)00250-4","article-title":"Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1 and CD4 down-regulation","volume":"78","author":"Peng","year":"2001","journal-title":"Immunol Lett"},{"key":"10.1016\/j.mehy.2006.12.012_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/viro.2000.0816","article-title":"HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway","volume":"282","author":"Swann","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.mehy.2006.12.012_bib38","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1128\/JVI.76.4.1626-1631.2002","article-title":"Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes","volume":"76","author":"Yang","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib39","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1128\/JVI.78.23.13335-13344.2004","article-title":"Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus","volume":"78","author":"Swigut","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00932-06","article-title":"The Entire Genome of a nef-Deleted Strain of Human Immunodeficency Virus Type 1 recovered 20 years after Primary Infection: large pool of env-deleted proviruses","author":"Calugi","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib41","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/emboj\/17.10.2777","article-title":"The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes","volume":"17","author":"Greenberg","year":"1998","journal-title":"Embo J"},{"key":"10.1016\/j.mehy.2006.12.012_bib42","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/JVI.73.3.1964-1973.1999","article-title":"Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking","volume":"73","author":"Mangasarian","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib43","doi-asserted-by":"crossref","first-page":"17543","DOI":"10.1073\/pnas.0509078102","article-title":"Seeing is believing: structure of the catalytic domain of HIV-1 integrase in complex with human LEDGF\/p75","volume":"102","author":"Bradley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2006.12.012_bib44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tig.2006.05.006","article-title":"Retroviral DNA integration: HIV and the role of LEDGF\/p75","volume":"22","author":"Ciuffi","year":"2006","journal-title":"Trends Genet"},{"key":"10.1016\/j.mehy.2006.12.012_bib45","article-title":"Over-expression of the LEDGF\/p75 Integrase binding domain inhibits HIV replication","author":"De Rijck","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1126\/science.1132319","article-title":"An essential role for LEDGF\/p75 in HIV integration","volume":"314","author":"Llano","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mehy.2006.12.012_bib47","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/JVI.80.4.1886-1896.2006","article-title":"Transient and stable knockdown of the integrase cofactor LEDGF\/p75 reveals its role in the replication cycle of human immunodeficiency virus","volume":"80","author":"Vandekerckhove","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib48","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1242\/jcs.02995","article-title":"Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin","volume":"119","author":"Maertens","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.mehy.2006.12.012_bib49","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/nar\/gkl052","article-title":"A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF\/p75 with chromatin in vivo","volume":"34","author":"Turlure","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.mehy.2006.12.012_bib50","article-title":"Structure-based mutagenesis of the integrase-LEDGF\/p75 interface uncouples a strict correlation between in vitro protein binding and HIV-1 fitness","author":"Rahman","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.mehy.2006.12.012_bib51","doi-asserted-by":"crossref","first-page":"17308","DOI":"10.1073\/pnas.0506924102","article-title":"Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75","volume":"102","author":"Cherepanov","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2006.12.012_bib52","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nsmb937","article-title":"Solution structure of the HIV-1 integrase-binding domain in LEDGF\/p75","volume":"12","author":"Cherepanov","year":"2005","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.mehy.2006.12.012_bib53","doi-asserted-by":"crossref","first-page":"25517","DOI":"10.1074\/jbc.M501378200","article-title":"Integrase mutants defective for interaction with LEDGF\/p75 are impaired in chromosome tethering and HIV-1 replication","volume":"280","author":"Emiliani","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2006.12.012_bib54","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection","volume":"113","author":"Harris","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2006.12.012_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2006.12.012_bib56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA","volume":"424","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2006.12.012_bib57","doi-asserted-by":"crossref","first-page":"9259","DOI":"10.1128\/JVI.00888-06","article-title":"Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation","volume":"80","author":"Pace","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib58","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.cub.2003.10.034","article-title":"The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G","volume":"13","author":"Conticello","year":"2003","journal-title":"Curr Biol"},{"key":"10.1016\/j.mehy.2006.12.012_bib59","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm946","article-title":"HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation","volume":"9","author":"Marin","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2006.12.012_bib60","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.mehy.2006.12.012_bib61","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1249904","article-title":"Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation","volume":"18","author":"Mehle","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.mehy.2006.12.012_bib62","doi-asserted-by":"crossref","first-page":"17259","DOI":"10.1074\/jbc.M602413200","article-title":"A zinc-binding region in Vif binds Cul5 and determines cullin selection","volume":"281","author":"Mehle","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2006.12.012_bib63","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/JVI.80.6.3112-3115.2006","article-title":"Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F","volume":"80","author":"Tian","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib64","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1101\/gad.1250204","article-title":"Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines","volume":"18","author":"Yu","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.mehy.2006.12.012_bib65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.mehy.2004.07.015","article-title":"A new approach to an AIDS vaccine: creating antibodies to HIV vif will enable apobec3G to turn HIV-infection into a benign problem","volume":"64","author":"Jeffrey Fessel","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2006.12.012_bib66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2222\/jsv.55.281","article-title":"HIV budding and Tsg101","volume":"55","author":"Yasuda","year":"2005","journal-title":"Uirusu"},{"key":"10.1016\/j.mehy.2006.12.012_bib67","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2174\/1381612053764869","article-title":"Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome","volume":"11","author":"Barbaro","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.mehy.2006.12.012_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(01)00506-2","article-title":"Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding","volume":"107","author":"Garrus","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2006.12.012_bib69","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0092-8674(03)00714-1","article-title":"The protein network of HIV budding","volume":"114","author":"von Schwedler","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2006.12.012_bib70","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/01.aids.0000210619.75707.21","article-title":"Variability in the P6gag domains of HIV-1 involved in viral budding","volume":"20","author":"Holguin","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.mehy.2006.12.012_bib71","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection","volume":"100","author":"Richman","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2006.12.012_bib72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00002030-199002000-00002","article-title":"Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera","volume":"4","author":"Albert","year":"1990","journal-title":"AIDS"},{"key":"10.1016\/j.mehy.2006.12.012_bib73","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.0505126102","article-title":"Antibody vs. HIV in a clash of evolutionary titans","volume":"102","author":"Burton","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2006.12.012_bib74","doi-asserted-by":"crossref","first-page":"18514","DOI":"10.1073\/pnas.0504658102","article-title":"Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection","volume":"102","author":"Frost","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2006.12.012_bib75","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1128\/JVI.79.8.4991-4999.2005","article-title":"Enfuvirtide resistance mutations: impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization","volume":"79","author":"Reeves","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib76","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1128\/JVI.02706-05","article-title":"Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients","volume":"80","author":"Labrosse","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib77","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/apc.2006.20.489","article-title":"The hunt for HIV-1 integrase inhibitors","volume":"20","author":"Lataillade","year":"2006","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.mehy.2006.12.012_bib78","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1529\/biophysj.104.050286","article-title":"Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I\/M154I catalytic domain","volume":"88","author":"Brigo","year":"2005","journal-title":"Biophys J"},{"key":"10.1016\/j.mehy.2006.12.012_bib79","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1128\/JVI.78.11.5835-5847.2004","article-title":"Human immunodeficiency virus type 1 (HIV-1) integrase: resistance to diketo acid integrase inhibitors impairs HIV-1 replication and integration and confers cross-resistance to l-chicoric acid","volume":"78","author":"Lee","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib80","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1128\/JVI.02743-05","article-title":"3-O-(3\u2032,3\u2032-dimethysuccinyl) betulinic acid inhibits maturation of the human immunodeficiency virus type 1 Gag precursor assembled in vitro","volume":"80","author":"Sakalian","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2006.12.012_bib81","doi-asserted-by":"crossref","first-page":"13555","DOI":"10.1073\/pnas.2234683100","article-title":"PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing","volume":"100","author":"Li","year":"2003","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987706009145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987706009145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T17:00:14Z","timestamp":1683738014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987706009145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0306987706009145"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2006.12.012","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}